Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 14, 2012; 18(30): 4004-4011
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4004
Published online Aug 14, 2012. doi: 10.3748/wjg.v18.i30.4004
Figure 2 Distribution of faecal pyruvate kinase isoenzyme type M2 concentrations in a screening collective of 2787 participants aged from 45 to 65 years[52].
n: Number of test negative; N: Total number of subjects; M2-PK: Pyruvate kinase isoenzyme type M2.
- Citation: Tonus C, Sellinger M, Koss K, Neupert G. Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysis. World J Gastroenterol 2012; 18(30): 4004-4011
- URL: https://www.wjgnet.com/1007-9327/full/v18/i30/4004.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i30.4004